0000875320-24-000127.txt : 20240503 0000875320-24-000127.hdr.sgml : 20240503 20240503161835 ACCESSION NUMBER: 0000875320-24-000127 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240501 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKENZIE DIANA CENTRAL INDEX KEY: 0001754648 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 24913381 MAIL ADDRESS: STREET 1: METLIFE STREET 2: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 wk-form4_1714767498.xml FORM 4 X0508 4 2024-05-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001754648 MCKENZIE DIANA C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 0 Common Stock 2024-05-01 4 A 0 1001 0 A 3604 D Common Stock 2024-05-01 4 D 0 1168 D 2436 D Common Stock 207 I Held in Trust Deferred Stock Units 2024-05-01 4 A 0 1168 A Common Stock 1168 5990.483 D Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2023, Ms. McKenzie deferred the receipt of 1,168 shares of common stock and received instead 1,168 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,168 shares of common stock in exchange for an equal number of deferred stock units. Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. /s/ Christiana Stevenson, Attorney-in-Fact 2024-05-03